Our findings are in line with a previous study demonstrating that activated KRAS proto-oncogene and insulin-like growth factor 1 signaling induce MDM4 expression at least partially via ELK1 in breast, colon, and lung cancer cells [32]. Here, KRAS is linked to lung cancer.